Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
- Status
- COMPLETED
- Phase
- N/A
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
- Status
- COMPLETED
- Phase
- N/A
Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients
- Status
- TERMINATED
- Phase
- PHASE1
A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Special Investigation of COMIRNATY in the Population With Underlying Diseases
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
- Status
- TERMINATED
- Phase
- PHASE2
Retrospective Evaluation of Lung Pathology in Subjects With COVID-19
- Status
- COMPLETED
- Phase
- N/A
Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- N/A
Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)
- Status
- UNKNOWN
- Phase
- N/A
COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray
- Status
- WITHDRAWN
- Phase
- NA
Oxygen Saturation: Analytical Comparison for COVID
- Status
- WITHDRAWN
- Phase
- NA
Convalescent Plasma as Adjunct Therapy for COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Leveraging Social Networks to Increase COVID-19 Testing Uptake
- Status
- COMPLETED
- Phase
- NA
Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)
- Status
- TERMINATED
- Phase
- PHASE1
A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients
- Status
- TERMINATED
- Phase
- PHASE3
Convalescent Plasma Therapy - Zurich Protocol
- Status
- COMPLETED
- Phase
- PHASE1
SARS-CoV-2 Human Challenge Characterisation Study
- Status
- COMPLETED
- Phase
- NA